Latest Insider Transactions at Ardelyx, Inc. (ARDX)
This section provides a real-time view of insider transactions for Ardelyx, Inc. (ARDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ARDELYX, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ARDELYX, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,272
-2.86%
|
$51,360
$5.0 P/Share
|
|
Nov 30
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,000
-0.83%
|
$12,000
$4.5 P/Share
|
|
Nov 20
2023
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
11,368
-1.29%
|
$45,472
$4.36 P/Share
|
|
Nov 20
2023
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,873
-0.86%
|
$11,492
$4.36 P/Share
|
|
Nov 20
2023
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,714
-1.34%
|
$18,856
$4.36 P/Share
|
|
Nov 20
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
932
-0.82%
|
$3,728
$4.36 P/Share
|
|
Nov 20
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,835
-0.78%
|
$11,340
$4.36 P/Share
|
|
Nov 20
2023
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,581
-0.96%
|
$10,324
$4.36 P/Share
|
|
Nov 20
2023
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
2,835
-1.08%
|
$11,340
$4.36 P/Share
|
|
Nov 20
2023
|
Robert Ora Felsch Officer |
SELL
Open market or private sale
|
Direct |
1,044
-0.88%
|
$4,176
$4.36 P/Share
|
|
Nov 20
2023
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
2,384
-0.73%
|
$9,536
$4.36 P/Share
|
|
Nov 15
2023
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,000
-8.57%
|
$100,000
$4.0 P/Share
|
|
Oct 10
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,644
-0.45%
|
$6,576
$4.0 P/Share
|
|
Sep 08
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,897
-0.78%
|
$11,588
$4.55 P/Share
|
|
Aug 21
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
937
-0.84%
|
$2,811
$3.55 P/Share
|
|
Aug 21
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,846
-0.76%
|
$8,538
$3.55 P/Share
|
|
Aug 21
2023
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,591
-0.88%
|
$7,773
$3.55 P/Share
|
|
Aug 21
2023
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,733
-1.34%
|
$14,199
$3.55 P/Share
|
|
Aug 21
2023
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
2,392
-0.72%
|
$7,176
$3.55 P/Share
|
|
Aug 21
2023
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
11,419
-1.29%
|
$34,257
$3.55 P/Share
|
|
Aug 21
2023
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,884
-0.86%
|
$8,652
$3.55 P/Share
|
|
Aug 21
2023
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
2,846
-1.07%
|
$8,538
$3.55 P/Share
|
|
Aug 21
2023
|
Robert Ora Felsch Officer |
SELL
Open market or private sale
|
Direct |
1,048
-0.9%
|
$3,144
$3.55 P/Share
|
|
Jun 27
2023
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,000
-7.83%
|
$75,000
$3.35 P/Share
|
|
Jun 23
2023
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
33,333
-11.13%
|
$99,999
$3.63 P/Share
|
|
Jun 23
2023
|
Robert Blanks Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,333
+10.02%
|
$99,999
$3.42 P/Share
|
|
Jun 15
2023
|
William C Bertrand Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,581
+7.05%
|
-
|
|
Jun 15
2023
|
Richard J Rodgers Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,494
+7.2%
|
-
|
|
Jun 15
2023
|
Onaiza Cadoret Manier Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,755
+10.38%
|
-
|
|
Jun 15
2023
|
Jan M Lundberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,755
+7.99%
|
-
|
|
Jun 15
2023
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,510
+2.09%
|
-
|
|
May 23
2023
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
2,384
-0.72%
|
$7,152
$3.65 P/Share
|
|
May 23
2023
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
11,357
-1.26%
|
$34,071
$3.65 P/Share
|
|
May 23
2023
|
Robert Ora Felsch Officer |
SELL
Open market or private sale
|
Direct |
1,046
-0.89%
|
$3,138
$3.65 P/Share
|
|
May 23
2023
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,583
-0.8%
|
$7,749
$3.65 P/Share
|
|
May 23
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
934
-0.83%
|
$2,802
$3.65 P/Share
|
|
May 23
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,835
-0.75%
|
$8,505
$3.65 P/Share
|
|
May 23
2023
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,711
-1.32%
|
$14,133
$3.65 P/Share
|
|
May 23
2023
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,873
-0.85%
|
$8,619
$3.65 P/Share
|
|
May 23
2023
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
2,835
-1.05%
|
$8,505
$3.65 P/Share
|
|
Mar 29
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
3,000
-2.58%
|
$12,000
$4.63 P/Share
|
|
Feb 21
2023
|
Susan Rodriguez Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,586
-1.55%
|
$16,758
$3.0 P/Share
|
|
Feb 21
2023
|
Justin A Renz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,439
-1.01%
|
$10,317
$3.0 P/Share
|
|
Feb 21
2023
|
Robert Ora Felsch Officer |
SELL
Open market or private sale
|
Direct |
3,214
-2.74%
|
$9,642
$3.0 P/Share
|
|
Feb 21
2023
|
Michael Raab President & CEO |
SELL
Open market or private sale
|
Direct |
13,449
-1.48%
|
$40,347
$3.0 P/Share
|
|
Feb 21
2023
|
Elizabeth A Grammer Officer |
SELL
Open market or private sale
|
Direct |
2,914
-0.88%
|
$8,742
$3.0 P/Share
|
|
Feb 21
2023
|
Robert Blanks Officer |
SELL
Open market or private sale
|
Direct |
3,394
-1.25%
|
$10,182
$3.0 P/Share
|
|
Feb 21
2023
|
Laura A Williams Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,187
-0.99%
|
$9,561
$3.0 P/Share
|
|
Feb 21
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Indirect |
1,114
-0.98%
|
$3,342
$3.0 P/Share
|
|
Feb 21
2023
|
David P. Rosenbaum Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,394
-0.9%
|
$10,182
$3.0 P/Share
|